Bloomberg -- Gedeon Richter Nyrt., Hungary’s largest drugmaker, said that the Phase II clinical trial of Cariprazine for bipolar depression produced no “statistically significant” result compared with placebo treatment.
Bloomberg -- Gedeon Richter Nyrt., Hungary’s largest drugmaker, said that the Phase II clinical trial of Cariprazine for bipolar depression produced no “statistically significant” result compared with placebo treatment.
